Stock News MindMed re-establishes Nasdaq listing requirements News follows a 1-for-15 reverse share split by the company at the end of August and ensuing loss of stock value Rowan DunneSeptember 14, 2022
Cannabis Delix gets recognized as leading start-up by Nature Biotechnology Renowned academic journal praises company for development of psychoplastogens Rowan DunneSeptember 14, 2022
Canada DOSED 2 screening sells out at Vancouver’s Rio Theatre Film screening was followed by audience Q&A session hosted by director Rowan DunneSeptember 13, 2022
Canada Algernon receives approval to conduct DMT study in the Netherlands New clinical research will assess efficacy of IV formulation for the treatment of strokes Rowan DunneSeptember 12, 2022
Canada Optimi makes history with gargantuan psilocybin harvest Company believes it has completed the largest mushroom harvest Canada has ever seen Rowan DunneSeptember 9, 2022
US San Fran lawmakers motion to decriminalize psychedelic plants Psychoactive plants like psilocybin mushrooms and ayahuasca will no longer be condemned in California city Rowan DunneSeptember 8, 2022
Psychedelics Xtalks to host upcoming webinar on psychedelic know-how Free virtual conference will discuss unique requisites of psychedelic clinical development Rowan DunneSeptember 7, 2022
Research Psychedelic use rising as the market expands: MicroSmallCap New report outlines statistics and recent accomplishments made in the field Rowan DunneSeptember 6, 2022
Canada Field Trip facilitates beneficial psychedelic-assisted therapy for cancer patient Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada Rowan DunneSeptember 2, 2022
Canada Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program Rowan DunneSeptember 1, 2022